T-TAS®01 – The Leading Edge in Primary Hemostasis Assessment
Posted on: March 22, 2021
This is an archived edition of our email newsletter.
It’s Not Just Support. It’s Solutions.
Discover the Leading Edge in Primary Hemostasis Assessment
Global evaluation of overall hemostatic ability using physiologic, flow conditions. Exclusively from DiaPharma.
Advantages of T-TAS® 01
Ease of Interpretation
A numeric cut-off easily identifies those with primary hemostasis disorders, assisting with more timely determination of appropriate treatment strategy
Reduced Costs
May need fewer blood draws, as extra tests may be eliminated, improving the patient’s experience as well as eliminating the associated costs
Simple Pre-Analytics
Fewer blood draws without required fasting improves the patient’s (and phlebotomist’s) experience
Direct use of whole blood minimizes pre-analytical errors
Rapid
Results in 10 minutes makes T-TAS® 01 a valid POC platelet function test
Physiologically Relevant
T-TAS® 01 reconstructs in vivo blood flow conditions
Learn More |
For in vitro diagnostic use.
Explore our wide portfolio of hemostasis assays from DiaPharma.
It’s Not Just Support. It’s Solutions.
Our scientific experts and customer support teams are just a call or click away.
Contact Us |
Copyright © 2021 DiaPharma Group, Inc. All rights reserved.
DiaPharma Group, Inc., 8948 Beckett Rd, West Chester, OH 45069
ML-00-00785Rev01